Aparna R. Parikh, MD, medical oncologist, Massachusetts General Hospital, discusses liquid biopsies in gastrointestinal (GI) cancers.

In an effort to better understand acquired resistance to targeted therapies in GI cancers, investigators collected plasma via liquid biopsy at disease progression for next-generation sequencing of circulating tumor DNA.

Tissue biopsies may not capture the entirety of the tumor in terms of heterogeneity, says Parikh.

View more from the 2017 World Congress on GI Cancer

Conference

® Conference page includes a listing of all conferences covered by 

, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.


Gastrointestinal Cancer

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

ESMO World Congress on Gastrointestinal Cancer

Aparna R. Parikh, MD, medical oncologist, Massachusetts General Hospital, discusses liquid biopsies in gastrointestinal cancers.
 

Dr. Parikh Discusses Liquid Biopsies in Gastrointestinal Cancers